Blood-based genomics of triple-negative breast cancer progression in patients treated with neoadjuvant chemotherapy

BACKGROUND: As neoadjuvant chemotherapy (NAC) is increasingly used in triple-negative breast cancer (TNBC), we investigated the value of circulating tumor DNA (ctDNA) for patient monitoring prior, during, and after NAC, and circulating tumor cells (CTCs) for disease characterization at clinical prog...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:ESMO Open
Hauptverfasser: Ortolan, E., Appierto, V., Silvestri, M., Miceli, R., Veneroni, S., Folli, S., Pruneri, G., Vingiani, A., Belfiore, A., Cappelletti, V., Vismara, M., Dell'Angelo, F., De Cecco, L., Bianchi, G.V., de Braud, F.G., Daidone, M.G., Di Cosimo, S.
Format: Artigo
Sprache:Inglês
Veröffentlicht: Elsevier 2021
Schlagworte:
Original Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8010400/
https://ncbi.nlm.nih.gov/pubmed/33743331
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.esmoop.2021.100086
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge